ENDRA Life Sciences (NDRA) Free Cash Flow (QoQ) (2016 - 2026)
Powered by 
Analysis
ENDRA Life Sciences (NDRA) Free Cash Flow (QoQ) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.16% |
| Mar 31, 2026 | 30.53% |
| Dec 31, 2025 | -38.46% |
| Sep 30, 2025 | -4.52% |
| Jun 30, 2025 | 15.01% |
| Mar 31, 2025 | 13.54% |
| Dec 31, 2024 | 8.54% |
| Sep 30, 2024 | 20.03% |
| Jun 30, 2024 | 4.56% |
| Mar 31, 2024 | 0.47% |
| Dec 31, 2023 | 16.06% |
| Sep 30, 2023 | -14.55% |
| Jun 30, 2023 | 10.47% |
| Mar 31, 2023 | 18.98% |
| Dec 31, 2022 | 4.12% |
| Sep 30, 2022 | 3.92% |
| Jun 30, 2022 | -6.48% |
| Mar 31, 2022 | -20.19% |
| Dec 31, 2021 | 3.42% |
| Sep 30, 2021 | 1.88% |